Damian Wild

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 15

Top Topics

Neuroendocrine Tumors

Positron Emission Tomography

Quality Control

Top Venues

European journal of nuclear medicine and molecular imaging

EJNMMI research

The Journal of clinical endocrinology and metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Julia Fricke, Frida Westerbergh, Lisa McDougall, Chiara Favaretto, Emanuel Christ, Guillaume P Nicolas, Susanne Geistlich, Francesca Borgna, Melpomeni Fani, Peter Bernhardt, Nicholas P van der Meulen, Cristina Müller, Roger Schibli, Damian Wild
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European journal of nuclear medicine and molecular imaging 51 (8) (2024)
Christof Rottenburger, Michael Hentschel, Markus Fürstner, Lisa McDougall, Danijela Kottoros, Felix Kaul, Rosalba Mansi, Melpomeni Fani, A Hans Vija, Roger Schibli, Susanne Geistlich, Martin Behe, Emanuel R Christ, Damian Wild
In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [ 177 Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI research 14 (1) (2024)
Julia Fricke, Frida Westerbergh, Lisa McDougall, Chiara Favaretto, Emanuel Christ, Guillaume P Nicolas, Susanne Geistlich, Francesca Borgna, Melpomeni Fani, Peter Bernhardt, Nicholas P van der Meulen, Cristina Müller, Roger Schibli, Damian Wild
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European journal of nuclear medicine and molecular imaging (2024)
Christof Rottenburger, Michael Hentschel, Markus Fürstner, Lisa McDougall, Danijela Kottoros, Felix Kaul, Rosalba Mansi, Melpomeni Fani, A Hans Vija, Roger Schibli, Susanne Geistlich, Martin Behe, Emanuel R Christ, Damian Wild
In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [ 177 Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI research 14 (1) (2024)
Julia Fricke, Frida Westerbergh, Lisa McDougall, Chiara Favaretto, Emanuel Christ, Guillaume P Nicolas, Susanne Geistlich, Francesca Borgna, Melpomeni Fani, Peter Bernhardt, Nicholas P van der Meulen, Cristina Müller, Roger Schibli, Damian Wild
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European journal of nuclear medicine and molecular imaging 51 (8) (2024)
Julia Fricke, Frida Westerbergh, Lisa McDougall, Chiara Favaretto, Emanuel Christ, Guillaume P Nicolas, Susanne Geistlich, Francesca Borgna, Melpomeni Fani, Peter Bernhardt, Nicholas P van der Meulen, Cristina Müller, Roger Schibli, Damian Wild
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European journal of nuclear medicine and molecular imaging 51 (8) (2024)
Julia Fricke, Frida Westerbergh, Lisa McDougall, Chiara Favaretto, Emanuel Christ, Guillaume P Nicolas, Susanne Geistlich, Francesca Borgna, Melpomeni Fani, Peter Bernhardt, Nicholas P van der Meulen, Cristina Müller, Roger Schibli, Damian Wild
First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([ 161 Tb]Tb-DOTA-LM3) in a patient with a metastatic neuroendocrine tumour of the ileum. European journal of nuclear medicine and molecular imaging 51 (8) (2024)
Christof Rottenburger, Michael Hentschel, Markus Fürstner, Lisa McDougall, Danijela Kottoros, Felix Kaul, Rosalba Mansi, Melpomeni Fani, A Hans Vija, Roger Schibli, Susanne Geistlich, Martin Behe, Emanuel R Christ, Damian Wild
In-vivo inhibition of neutral endopeptidase 1 results in higher absorbed tumor doses of [ 177 Lu]Lu-PP-F11N in humans: the lumed phase 0b study. EJNMMI research 14 (1) (2024)
Moira Schmidlin, Samira M Sadowski, Alexander Siebenhüner, Damian Wild, Emanuel Christ, Julie C Refardt
Improvement of Lung NET Management through Standardized Care-A Swiss Nationwide Observational Study. Cancers 15 (8) (2023)
Moira Schmidlin, Samira M Sadowski, Alexander Siebenhüner, Damian Wild, Emanuel Christ, Julie C Refardt
Improvement of Lung NET Management through Standardized Care-A Swiss Nationwide Observational Study. Cancers 15 (8) (2023)
Nikola Doncic, Christoph J Zech, Damian Wild, Helga Bachmann, Makhmudbek Mallaev, Nikolay Tsvetkov, Aljaz Hojski, Martin T L Takes, Didier Lardinois
CT-guided percutaneous marking of small pulmonary nodules with [ 99m Tc]Tc-Macrosalb is very accurate and allows minimally invasive lung-sparing resection: a single-centre quality control. European journal of nuclear medicine and molecular imaging (2023)
Julie C Refardt, Johannes Hofland, Damian Wild, Emanuel R Christ
Molecular Imaging of Neuroendocrine Neoplasms. The Journal of clinical endocrinology and metabolism 107 (7) (2022)
Sho Hasegawa, Noritoshi Kobayashi, Damian Wild, Fesupplix Kaul, Naoki Okubo, Akihiro Suzuki, Yusuke Kurita, Shoko Takano, Hirokazu Takahashi, Yasushi Ichikawa
Factors Contributing to Tumor Shrinkage after Peptide Receptor Radionuclide Therapy in Patients with Unresectable Neuroendocrine Tumors. Cancers 14 (14) (2022)
Rodney John Hicks, Clarisse Dromain, Wouter W de Herder, Frederico P Costa, Christophe M Deroose, Andrea Frilling, Anna Koumarianou, Eric P Krenning, Eric Raymond, Lisa Bodei, Halfdan Sorbye, Staffan Welin, Bertram Wiedenmann, Damian Wild, James R Howe, James C Yao, Dermot O'Toole, Anders Sundin, Vikas Prasad
ENETS standardized (synoptic) reporting for molecular imaging studies in neuroendocrine tumours. Journal of neuroendocrinology (2021)
Kwadwo Antwi, Melpomeni Fani, Tobias Heye, Guillaume Nicolas, Christof Rottenburger, Felix Kaul, Elmar Merkle, Christoph J Zech, Daniel Boll, Deborah R Vogt, Beat Gloor, Emanuel Christ, Damian Wild
Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET/CT, SPECT/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study. European journal of nuclear medicine and molecular imaging 45 (13) (2018)